LOW-VOLUME · HOSP-HEAVY
anidulafungin Side Effects
anidulafungin (also sold as Eraxis) is a LOW-VOLUME FAERS extract #474 of 524 by FAERS report count. Still opens on HOSP-HEAVY: 48.5% mention hospitalization (741 reports).
Data updated 2026-05-15
- 1,527
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
anidulafungin: 48.5% mention hospitalization (741 reports). Death stamp DEATH-HEAVY; volume band LOW-VOLUME #474 of 524 by FAERS report count.
Thinner FAERS extract for anidulafungin (Eraxis) (1,527 reports #474 of 524 by FAERS report count). 48.5% mention hospitalization (741 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2006–2025). Stamps SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
MULTIPLE ORGAN DYSFUNCTION SYNDROME leads 171 of 1,527 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (484 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (665 reports, 43.5%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 147 |
| SEPTIC SHOCK | 87 |
| DEATH | 81 |
| SEPSIS | 75 |
| PNEUMONIA | 56 |
| RENAL FAILURE | 47 |
| DISSEMINATED INTRAVASCULAR COAGULATION | 44 |
| NEUTROPENIA | 43 |
| CANDIDA INFECTION | 41 |
| CONTRAINDICATED PRODUCT ADMINISTERED | 34 |
| HYPOTENSION | 34 |
| CONDITION AGGRAVATED | 33 |
| COVID-19 PNEUMONIA | 32 |
| DIARRHOEA | 30 |
| SCEDOSPORIUM INFECTION | 29 |
| ANAEMIA | 28 |
| IMMUNOSUPPRESSANT DRUG LEVEL INCREASED | 28 |
| ENTEROCOCCAL INFECTION | 25 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (741, 48.5% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 94 |
| SEPTIC SHOCK | 80 |
| PYREXIA | 63 |
| SEPSIS | 62 |
| PNEUMONIA | 42 |
| ACUTE KIDNEY INJURY | 41 |
| ENTEROCOCCAL INFECTION | 40 |
| RESPIRATORY FAILURE | 40 |
| NEUTROPENIA | 38 |
| HYPOTENSION | 35 |
| THROMBOCYTOPENIA | 34 |
| CANDIDA INFECTION | 32 |
| RENAL FAILURE | 31 |
| COVID-19 PNEUMONIA | 30 |
| DRUG RESISTANCE | 30 |
| FEBRILE NEUTROPENIA | 30 |
| DRUG INTERACTION | 29 |
| CONTRAINDICATED PRODUCT ADMINISTERED | 28 |
How to read anidulafungin FAERS figures (SIGNAL · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 1,527 voluntary reports linked to anidulafungin (Eraxis), 2006-2025. Death is listed on 665 (43.5%). Hospitalization appears on 741 (48.5%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with anidulafungin
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 1,538 FAERS cases (Δ 11 heavier vs anidulafungin); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 1,541 FAERS cases (Δ 14 heavier vs anidulafungin); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 1,547 FAERS cases (Δ 20 heavier vs anidulafungin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 1,551 FAERS cases (Δ 24 heavier vs anidulafungin); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 0.0% death-mentioned reports (Δ 43.5 pp vs anidulafungin's DEATH-HEAVY): MEGA-CASE · HOSP-LIGHT.
anidulafungin stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload SIGNAL and the label guide.